Beleave (CSE:BE)

Beleave is a biotech company with a focus on becoming a licensed producer of medical-grade cannabis under the ACMPR. Its wholly-owned subsidiary, First Access, applied for a pre-license inspection in March 2017.

Following that, on May 5 the company announced it had entered into an interim streaming agreement with PanCann to finance the purchase and construction of a second production facility.  In mid-May, Beleave finally announced it had received its ACMPR license to cultivate medical cannabis.